#ESKD

2 weeks ago

Funding required to establish ESKD registry, hears INS meeting

https://bit.ly/4c6Wa43

@IrishKidneyAs @IrishNephSoc #ESKD #CKD

0 0 0 0

3 weeks ago

Funding required to establish ESKD registry, hears INS meeting

https://bit.ly/4c6Wa43

@IrishKidneyAs @IrishNephSoc #ESKD #CKD

0 0 0 0

3 weeks ago

Funding required to establish ESKD registry, hears INS meeting

https://bit.ly/4c6Wa43

@IrishKidneyAs @IrishNephSoc #ESKD #CKD

0 0 0 0

1 month ago

Funding required to establish ESKD registry, hears INS meeting

https://bit.ly/4c6Wa43

@IrishKidneyAs @IrishNephSoc #ESKD #CKD

0 0 0 0

Christos Argyropoulos MD, PhD, FASN 🇺🇸 0kale/acc

1 month ago

Funding required to establish ESKD registry, hears INS meeting

https://bit.ly/4c6Wa43

@IrishKidneyAs @IrishNephSoc #ESKD #CKD

0 0 0 0

@christosargyrop.bsky.social

2 months ago

The PISCES trial creates some a interesting conundrum for D&I. On the one hand we have a very solid result found in a well executed trial. On the other hand we have an intervention that has not… | Christos Argyropoulos The PISCES trial creates some a interesting conundrum for D&I. On the one hand we have a very solid result found in a well executed trial. On the other hand we have an intervention that has not dazzled...

Some thoughts about replicating the PISCES trial of #fishoils in individuals with #ESKD receiving #hemodialysis
#nephrology #cardiology #nutrition

www.linkedin.com/posts/chrisa...

3 0 0 2

Christos Argyropoulos MD PhD

@christosargyrop.mastodon.social.ap.brid.gy

2 months ago

The PISCES trial creates some a interesting conundrum for D&I. On the one hand we have a very solid result found in a well executed trial. On the other hand we have an intervention that has not… | Christos Argyropoulos The PISCES trial creates some a interesting conundrum for D&I.; On the one hand we have a very solid result found in a well executed trial. On the other hand we have an intervention that has not dazzled the world in non-dialysis settings and despite the credible arguments about dose and prevailing "n3 deficiency in ESRD) these previous underwhelming results make nephrologists skeptical. Skepticism demands replication, but how can one replicate? Here are my thoughts: First, the intervention: the fish oils used in replication should be of the same amount (4g/day) and composition (EPA/DHA ratio of 2:1 to deliver at least 2.4 of the former and 0.8 g of the latter) Second, the outcome: it makes little sense to power against a precise relative risk since this would inflate the sample size. Instead, I would power against a directional outcome: the intervention should deliver a benefit at least as great as things as we adopted in the past. For example high flux dialyzers were eventually associated with reductions in cardiovascular and all cause mortality of around 15 to 20%. Third the design. I presume everyone will like to run this on the cheap by adopting a cluster randomized design but this would be a non-smart design in my opinion for a number of reasons: there are still seasonal and covid / flu related variations in morbidity and mortality, so unless you can get the right units enrolled and delivery synchronized, you will end up confounding results with these trends. Even in the absence of such trends, variability in mortality among dialysis units is HUGE , so why shoot yourself in the foot by basing the results on a design that is open to this confounding? Finally variation in diet and intake of n3 by region would also unnecessarily increase variation and noise in the results. For these reasons, a traditional design that randomizes in strata of units would be preferable. Having done the tedious work of armchair thinking, when can we start the replication?

Some thoughts about replicating the PISCES trial of #fishoils in individuals with #ESKD receiving #hemodialysis
#nephrology #cardiology #nutrition

www.linkedin.com/posts/chrisarg_the-pisce...

2 1 0 0

Katherine Thomasset

@kaththomasset.bsky.social

3 months ago

Classification of #diabetes into #subtypes predicts onset of #ESKD at an earlier stage, allowing for intervention #DiabetesResearch

0 0 0 0

Sayna Norouzi, MD

@saynanorouzi.bsky.social

4 months ago

🔥 Brilliant session by the legendary Dr. Glassock at the #GlomCon Fellowship!

Limiting #LupusNephritis flares is JUST as important as treatment.
✅ Prevent relapses → ↓ risk of #ESKD
🎯 Goal: Immunological remission (normal complements, neg. anti-dsDNA)

@glomcon.org

2 0 0 0

Kidney International

@kidneyint.bsky.social

4 months ago

Inactivation of Pkd2 in adult mice results in delayed cyst formation and identifies sex as a major modifier of disease severity.

doi.org/10.1016/j.kint.2025.08.039

#OpenAccess #NephSky #MedSky #ADPKD #ESKD

1 1 0 0

UW Nephrology

@uwnephrology.bsky.social

5 months ago

Simon Hsu, MD, MS - Managing Bone Disease in CKD: The State of the Evidence YouTube video by University of Washington Division of Nephrology

"Managing Bone Disease in CKD", presented by Dr. Simon Hsu @uwmedicine.bsky.social. Are fracture incidences higher
in #CKD and #ESKD? Do VitD3, cinacalcet, or denosumab help with prevention? What are all the considerations for #kidney and #bone health? #nephsky Watch: youtu.be/Pp9CuWIXl7k

2 1 0 0

5 months ago

Longitudinal Income Dynamics and Risk of End-Stage Kidney Disease in Type 2 Diabetes: A South Korean Population–Based Cohort Study

bit.ly/KangOI25

#ESKD #VisualAbstract

0 0 0 0

Michael Maattanen Needs a Kidney | Can You Help? Michael Maattanen Needs a Kidney | Can You Help?

6 months ago

Patients with CGS have a variable clinical course and may reach ESKD later than previously reported, even in the absence of mosaicism. Some patients with CGS may have a kidney phenotype similar to severe ADPKD. Other patients with CGS may have TSC manifestations associated with severe progression of cystic kidney disease but not as fast as previously expected for CGS.

TSC2/PKD1 Contiguous Gene Deletion Syndrome: A Case Series

bit.ly/Valle25OI

#ADPKD #ESKD #VisualAbstract

0 0 0 0

VoidedMike

@voidedmike.bsky.social

6 months ago

I’m searching for a living kidney donor. Sharing this could save my life. Every share helps me get closer to finding a match. 💚

👉 nkr.org/PZG643
#KidneyDonation #LivingDonor #OrganDonation #ESKD #ChronicIllness #DonateLife

2 0 0 0

Rolando Claure

@runningkidneys.bsky.social

6 months ago

Social Deprivation as a Key Driver of Spatial Disparities in End-Stage Kidney Disease Incidence AbstractBackground. Despite France's universal healthcare system, significant geographic disparities in the incidence of end-stage kidney disease (ESKD) pe

Social deprivation is the main driver of disparities in ESKD incidence in 🇫🇷 , explaining ~35% of spatial variability—more than diabetes or access to care. Even with universal healthcare, addressing #SDoH is key to reducing kidney disease burden. #ESKD
doi.org/10.1093/ckj/...

0 0 0 0

7 months ago

Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data

bit.ly/Gao25OI

#ESKD #EHR #VisualAbstract

1 1 0 0

7 months ago

Longitudinal Income Dynamics and Risk of End-Stage Kidney Disease in Type 2 Diabetes: A South Korean Population–Based Cohort Study

bit.ly/KangOI25

#ESKD #VisualAbstract

2 1 0 0

@kireports.bsky.social

7 months ago

Risk of End-Stage Kidney Disease #ESKD and #Topiramate Use

#VisualAbstract by @Cteodosiu

www.kireports.org/ar...

3 0 1 0

VoidedMike

@voidedmike.bsky.social

7 months ago

My live kidney donor backed out for valid personal reasons. They were a match, but it was always their choice. I’m not giving up. My team is still preparing me in case a match—living or deceased—comes through. #KidneyTransplant #DonateLife #ChronicIllness #ESKD

2 0 0 0

@chronicallyunited.bsky.social

8 months ago

TSC2/PKD1 Contiguous Gene Deletion Syndrome: A Case Series

bit.ly/Valle25OI

#ADPKD #ESKD

0 0 0 0

8 months ago

Kidney dialysis industry accused of maximizing profits over patients YouTube video by CBS Sunday Morning

📢 Dialysis patients deserve better.
CBS exposed DaVita & Fresenius for putting profits over care.
As patients, we must speak up when something feels off. Your health matters. Your voice matters.
#ChronicIllness #ESKD #Dialysis #PatientRights #DisabledVoices

youtu.be/ioJ0xb3w8nY?...

2 1 0 0

VoidedMike

@voidedmike.bsky.social

8 months ago

Kidney dialysis industry accused of maximizing profits over patients YouTube video by CBS Sunday Morning

youtu.be/ioJ0xb3w8nY?... Take care of your kidneys. CBS exposed DaVita & Fresenius for putting profit over patients. I used to doubt that. Now? It tracks. Speak up if something feels off — it might be. You deserve real care.
#DisabilityRights #Dialysis #ESKD #HealthJustice #BlindCommunity

2 0 0 0

Nephrology Times

@nephtimes.bsky.social

8 months ago

Fibrate Use Linked to Higher CKD Risk, Lower ESKD and Mortality Risk in Large Study | Docwire News In a large, retrospective study, fibrate use was associated with a higher risk for chronic kidney disease (CKD) but lower risk for end-stage kidney disease (ESKD) and mortality.

Fibrate use is associated with higher incidence of #CKD but lower risk for #ESKD and #mortality, a study found. #fibrate #kidneydisease #nephrology #nephsky www.docwirenews.com/post/fibrate...

2 0 0 0

KimK ... one day at a time 🇨🇦

@topazstudioscom.bsky.social

9 months ago

Safe Medication Use with Chronic Kidney Disease Some medicines can damage your kidneys. Many more are removed by your kidneys. Read more to learn about using medications safely when living with CKD.

Safe Medication Use with Chronic #Kidney Disease

www.kidney.org/kidney-topic... ... #CKD #ESKD

0 0 0 0